Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 227 institutions that hold shares in the stock, with a total of 149 Million shares, which have been reported (via 13F filing form) to have a value of $2.81 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,900,215
shares
|
$35.8 Million
0.0% of portfolio
|
Q3 2025
Added 41.76%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,898,950
shares
|
$35.8 Million
0.77% of portfolio
|
Q3 2025
New holding
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2025 Q3 2025 |
1,717,807
shares
|
$32.4 Million
0.04% of portfolio
|
Q3 2025
Added 1293.37%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
1,446,361
shares
|
$27.2 Million
3.31% of portfolio
|
Q2 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
1,419,007
shares
|
$26.7 Million
0.0% of portfolio
|
Q3 2025
Added 4.17%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
1,398,530
shares
|
$26.3 Million
0.0% of portfolio
|
Q3 2025
Added 0.6%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
1,398,087
shares
|
$26.3 Million
0.0% of portfolio
|
Q3 2025
Reduced 41.35%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
1,262,674
shares
|
$23.8 Million
3.17% of portfolio
|
Q3 2025
Added 376.52%
|
|
|
Abrdn PLC
|
Jan 16, 2026 Q4 2025 |
1,108,145
shares
|
$20.9 Million
0.03% of portfolio
|
Q4 2025
Added 99.04%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,037,568
shares
|
$19.5 Million
0.0% of portfolio
|
Q3 2025
Added 23.37%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
1,007,194
shares
|
$19 Million
0.0% of portfolio
|
Q3 2025
Added 35.18%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2025 Q3 2025 |
985,828
shares
|
$18.6 Million
0.76% of portfolio
|
Q3 2025
Added 60.33%
|
|
|
Frontier Capital Management CO LLC
|
Nov 14, 2025 Q3 2025 |
910,919
shares
|
$17.2 Million
0.11% of portfolio
|
Q3 2025
Added 15.39%
|
|
|
Candriam S.C.A.
|
Nov 05, 2025 Q3 2025 |
833,922
shares
|
$15.7 Million
0.06% of portfolio
|
Q3 2025
Added 59.1%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
829,769
shares
|
$15.6 Million
0.01% of portfolio
|
Q3 2025
Added 4.77%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
824,061
shares
|
$15.5 Million
0.7% of portfolio
|
Q3 2025
Added 41.84%
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2025 Q3 2025 |
800,000
shares
|
$15.1 Million
0.77% of portfolio
|
Q3 2025
New holding
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2025 Q3 2025 |
785,915
shares
|
$14.8 Million
0.21% of portfolio
|
Q3 2025
Added 2.04%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
761,112
shares
|
$14.3 Million
0.0% of portfolio
|
Q3 2025
Added 48.13%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
729,606
shares
|
$13.7 Million
0.04% of portfolio
|
Q3 2025
New holding
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2025 Q3 2025 |
710,044
shares
|
$13.4 Million
0.03% of portfolio
|
Q3 2025
Reduced 10.25%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Nov 14, 2025 Q3 2025 |
702,884
shares
|
$13.2 Million
0.36% of portfolio
|
Q3 2025
Reduced 5.66%
|
|
|
Mpm Asset Management LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
682,376
shares
|
$12.9 Million
19.3% of portfolio
|
Q3 2024
Reduced 56.3%
|
|
|
Jain Global LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
644,082
shares
|
$12.1 Million
0.04% of portfolio
|
Q3 2025
Added 8.04%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
543,166
shares
|
$10.2 Million
0.0% of portfolio
|
Q2 2025
Added 50916.19%
|
|